You are here:
Publication details
Eslikarbazepin
Title in English | Eslicarbazepine |
---|---|
Authors | |
Year of publication | 2011 |
Type | Article in Periodical |
Magazine / Source | Remedia |
MU Faculty or unit | |
Citation | |
Field | Neurology, neurosurgery, neurosciences |
Keywords | eslicarbazepine; epilepsy; add-on therapy |
Description | Eslicarbazepine acetate (ESL)) is a novel antiepileptic drug that stabilizes the voltage-gated sodium channel. The recommended maintenance dosage after titration is 800-1200 mg given in a single daily dose. |
Related projects: |